Using DCIS Score To Quantify Risk Of IBE For Breast Cancer Patients

[News]

The ductal carcinoma in situ (DCIS) Score quantifies the risk of ipsilateral breast event (IBE) and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published in the Journal of the Nati...

More... (http://www.medicalnewstoday.com/releases/260054.php)